- $1.92bn
- $1.57bn
- $125.58m
Xencor Inc reports results for the quarter ended in June - Earnings Summary
Brief: Xencor Q2 EPS USD -0.37
Xencor Inc expected to post a loss of 80 cents a share - Earnings Preview
Xencor Inc expected to post a loss of 80 cents a share - Earnings Preview
Brief: Xencor Presents Clinical Results from Phase 1a Study of XmAb564 at EULAR 2023 Congress
Brief: Xencor Reports First Quarter 2023 Financial Results
Xencor Inc reports results for the quarter ended in March - Earnings Summary
Brief: Xencor posts Q1 EPS USD -1.02
Xencor Inc expected to post a loss of 66 cents a share - Earnings Preview
Xencor Inc expected to post a loss of 66 cents a share - Earnings Preview
Brief: Xencor Holds No Deposits Or Securities At Silicon Valley Bank
Brief: Xencor Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
Xencor Inc reports results for the quarter ended in December - Earnings Summary
Xencor Inc expected to post a loss of 79 cents a share - Earnings Preview
Xencor Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Xencor Highlights 2023 Corporate Priorities And Provides Portfolio Updates
Brief: Caris Life Sciences And Xencor Expand Target Discovery Collaboration For XMAB
Xencor up on beating Q3 sales estimates